Patents Assigned to CELLVIEW IMAGING INC.
  • Patent number: 10194804
    Abstract: A non-invasive measurement of biological tissue reveals information about the function of that tissue. Polarized light is directed onto the tissue, stimulating the emission of fluorescence, due to one or more endogenous fluorophors in the tissue. Fluorescence anisotropy is then calculated. Such measurements of fluorescence anisotropy are then used to assess the functional status of the tissue, and to identify the existence and severity of disease states. Such assessment can be made by comparing a fluorescence anisotropy profile with a known profile of a control.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: February 5, 2019
    Assignee: CELLVIEW IMAGING INC.
    Inventor: Ivana Ledesma
  • Patent number: 10004401
    Abstract: A non-invasive measurement of biological tissue reveals information about the function of that tissue. Polarized light is directed onto the tissue, stimulating the emission of fluorescence, due to one or more endogenous fluorophors in the tissue. Fluorescence anisotropy is then calculated. Such measurements of fluorescence anisotropy are then used to assess the functional status of the tissue, and to identify the existence and severity of disease states. Such assessment can be made by comparing a fluorescence anisotropy profile with a known profile of a control.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: June 26, 2018
    Assignee: CELLVIEW IMAGING INC.
    Inventor: Ivana Ledesma
  • Publication number: 20170112374
    Abstract: A method is provided for determining the thickness of a retina. A single beam is used to illuminate the retina of a patient. Interference between reflections off different layers within the retina cause autocorrelation in the returned signal. An FFT applied to the autocorrelation signal reveals the strongest autocorrelation, which indicates the distance between the nerve fiber layer (NFL) and the layers between the inner segment/outer segment (IS/OS) and the retinal pigment epithelium (RPE), the dominant scatterers. By analyzing autocorrelation, a single beam can be used. This avoids the problem of movement of the patient, arising in the use of a standard OCT interferometer, resulting in a simpler and less expensive technique of measuring retinal thickness.
    Type: Application
    Filed: June 16, 2015
    Publication date: April 27, 2017
    Applicant: CELLVIEW IMAGING INC.
    Inventors: Mark Hathaway, Rishard Weitz
  • Patent number: 9462951
    Abstract: A non-invasive measurement of biological tissue reveals information about the function of that tissue. Polarized light is directed onto the tissue, stimulating the emission of fluorescence, due to one or more endogenous fluorophors in the tissue. Fluorescence anisotropy is then calculated. Such measurements of fluorescence anisotropy are then used to assess the functional status of the tissue, and to identify the existence and severity of disease states. Such assessment can be made by comparing a fluorescence anisotropy profile with a known profile of a control.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: October 11, 2016
    Assignee: CELLVIEW IMAGING INC.
    Inventor: Ivana Ledesma